We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$496M
AUM Growth
+$20M
Cap. Flow
+$16.5M
Cap. Flow %
3.33%
Top 10 Hldgs %
30.96%
Holding
92
New
31
Increased
21
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$13.3M
2
ELV icon
Elevance Health
ELV
+$12.4M
3
RVTY icon
Revvity
RVTY
+$11.2M
4
BIIB icon
Biogen
BIIB
+$11.1M
5
HUM icon
Humana
HUM
+$9.89M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.6M
2
CI icon
Cigna
CI
+$14.9M
3
UHS icon
Universal Health Services
UHS
+$14.1M
4
ISRG icon
Intuitive Surgical
ISRG
+$11.7M
5
MRNA icon
Moderna
MRNA
+$10.7M

Sector Composition

Rank Sector Weight
1 Healthcare 96.57%
2 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
1
Elevance Health
ELV
$84.8B
$23.5M 4.72%
51,000
+26,000
+104% +$12.4M
CYTK icon
2
Cytokinetics
CYTK
$10.7B
$21.1M 4.25%
600,000
+200,000
+50% +$8.16M
INSP icon
3
Inspire Medical Systems
INSP
$1.73B
$18.7M 3.77%
80,000
+20,000
+33% +$5.06M
COO icon
4
Cooper Companies
COO
$14.6B
$14.9M 3.01%
160,000
+100,000
+167% +$8.6M
SYK icon
5
Stryker
SYK
$129B
$14.3M 2.88%
+50,000
New +$13.3M
ABBV icon
6
AbbVie
ABBV
$435B
$12.9M 2.6%
81,000
+31,000
+62% +$4.74M
RLAY icon
7
Relay Therapeutics
RLAY
$4.29B
$12.7M 2.55%
770,000
+145,000
+23% +$2.6M
VKTX icon
8
Viking Therapeutics
VKTX
$3.91B
$12.1M 2.44%
727,100
+127,100
+21% +$1.31M
HCA icon
9
HCA Healthcare
HCA
$88.7B
$11.9M 2.39%
45,000
+2,000
+5% +$508K
TFX icon
10
Teleflex
TFX
$6.06B
$11.7M 2.35%
46,000
+26,000
+130% +$6.3M
CAH icon
11
Cardinal Health
CAH
$56B
$11.5M 2.31%
152,000
+68,000
+81% +$5.13M
RVTY icon
12
Revvity
RVTY
$12.8B
$11.3M 2.28%
+85,000
New +$11.2M
BIIB icon
13
Biogen
BIIB
$30.5B
$11.1M 2.24%
+40,000
New +$11.1M
EXAS
14
DELISTED
Exact Sciences
EXAS
$11M 2.21%
162,000
-113,000
-41% -$7.26M
SRPT icon
15
PUT
Sarepta Therapeutics
SRPT
$1.68B
$10.3M 2.08%
+75,000
New +$9.73M
ZNTL icon
16
Zentalis Pharmaceuticals
ZNTL
$352M
$10.3M 2.08%
600,000
-150,000
-20% -$3.04M
SAGE
17
DELISTED
Sage Therapeutics
SAGE
$10.3M 2.07%
245,000
-115,000
-32% -$4.94M
QURE icon
18
uniQure
QURE
$3.07B
$10.1M 2.03%
500,000
-50,000
-9% -$1.05M
IDXX icon
19
Idexx Laboratories
IDXX
$46.1B
$10M 2.01%
+20,000
New +$9.57M
PEN icon
20
Penumbra
PEN
$12.7B
$9.75M 1.96%
35,000
+5,000
+17% +$1.28M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.6B
$9.72M 1.96%
100,000
-70,000
-41% -$7.26M
VTYX
22
DELISTED
Ventyx Biosciences
VTYX
$9.71M 1.96%
290,000
+80,000
+38% +$3.11M
HUM icon
23
Humana
HUM
$43.7B
$9.71M 1.96%
+20,000
New +$9.89M
MRK icon
24
Merck
MRK
$317B
$9.58M 1.93%
90,000
-60,000
-40% -$6.48M
PTCT icon
25
PTC Therapeutics
PTCT
$5.78B
$8.62M 1.74%
178,000
+78,000
+78% +$3.57M
1
2 3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Integral Health Asset Management held 92 positions worth $496M, up 4.2% from $476M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Integral Health Asset Management deployed $16.5M of net new capital in Q1 2023, opening 31 new positions and adding to 21 existing holdings. Its largest new stake was Stryker: 50,000 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 93% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Moderna, an estimated $10.7M trimmed.

  • Integral Health Asset Management's largest Q1 2023 buy was Stryker: 50,000 shares worth $14.3M.
  • Integral Health Asset Management added most to Elevance Health in Q1 2023, an estimated $12.4M increase.
  • Integral Health Asset Management's biggest Q1 2023 reduction was Moderna, cutting an estimated $10.7M.
  • Integral Health Asset Management fully exited Quest Diagnostics in Q1 2023, selling an estimated $15.6M.
  • Integral Health Asset Management's ten largest holdings make up 31% of its $496M portfolio in Q1 2023.
  • Integral Health Asset Management opened 31 new positions and closed 21 in Q1 2023.
  • Integral Health Asset Management's portfolio value rose 4.2% quarter-over-quarter to $496M.

Based on Integral Health Asset Management's 13F filing for Q1 2023, filed 9 May 2023.